Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach

Ebola virus (EBOV) is a dangerous zoonotic infectious disease. To date, more than 25 EBOV outbreaks have been documented, the majority of which have occurred in Central Africa. The rVSVG-ZEBOV-GP vaccine (ERVEBO), a live attenuated vaccine, has been approved by the US Food and Drug Administration (F...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizadeh, Morteza, Amini-Khoei, Hossein, Tahmasebian, Shahram, Ghatrehsamani, Mahdi, Ghatreh Samani, Keihan, Edalatpanah, Yadolah, Rostampur, Susan, Salehi, Majid, Ghasemi-Dehnoo, Maryam, Azadegan-Dehkordi, Fatemeh, Sanami, Samira, Bagheri, Nader
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094136/
https://www.ncbi.nlm.nih.gov/pubmed/35545650
http://dx.doi.org/10.1038/s41598-022-11851-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094136/
https://www.ncbi.nlm.nih.gov/pubmed/35545650
http://dx.doi.org/10.1038/s41598-022-11851-z

Ejemplares similares